BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/10/2024 11:51:40 AM | Browse: 294 | Download: 1018
 |
Received |
|
2023-12-25 07:45 |
 |
Peer-Review Started |
|
2023-12-25 07:45 |
 |
First Decision by Editorial Office Director |
|
2024-01-10 09:24 |
 |
Return for Revision |
|
2024-01-10 09:24 |
 |
Revised |
|
2024-02-01 09:45 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-03-13 12:25 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-03-20 05:56 |
 |
Articles in Press |
|
2024-03-20 05:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-29 00:31 |
 |
Publish the Manuscript Online |
|
2024-05-10 11:51 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Review |
| Article Title |
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mahmoud Emad-Eldin, Gehan F Balata, Eman A Elshorbagy, Mona S Hamed and Mohamed S Attia |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mahmoud Emad-Eldin, BPharm, MSc, Teaching Assistant, Department of Pharmacy Practice, Faculty of Pharmacy, Zagazig University, PO 44519, Zagazig HFQM+872, Al-Sharqia Governorate, Egypt. memadeldin@zu.edu.eg |
| Key Words |
Adherence; Diabetes; Insulin; Patient-reported outcomes; Pharmacokinetic; Pharmacodynamic |
| Core Tip |
Understanding the dynamics of insulin therapy in type 2 diabetes is crucial for the effective management of the disease. This review navigates through the evolution of insulin formulations, emphasizing the impact of different regimens on patient-reported outcomes. Adherence to insulin therapy, a pivotal factor for successful outcomes, is investigated alongside various insulin preparations and the influencing factors. Gaining insight into these dynamics can steer healthcare strategies, ultimately refining decision-making and boosting patient outcomes in type 2 diabetes management. |
| Publish Date |
2024-05-10 11:51 |
| Citation |
Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes 2024; 15(5): 828-852 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i5/828.htm |
| DOI |
10.4239/wjd.v15.i5.828 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.